CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 820 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02035059
NCT02035059N/ACompleted
CompareCT.gov

Predictability of Gestational Diabetes Mellitus in First and Second Trimester, Using Novel Biomarkers, and the Development of New Biomarkers by Quantitative Proteomic Analysis

University Hospital, Basel, Switzerland·observational·Posted Jan 14, 2014·Updated Apr 26, 2019

In Brief

An observational study for Pregnancy and Gestational Diabetes Mellitus. Completed, enrolled 820 participants across 1 site.

Detailed Summary

The objective of the study is, if an early oral glucose tolerance test combined with maternal history, condition and multiple biomarker analysis can be used to detect gestational diabetes mellitus in the first trimester (12-14 weeks of gestation).

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPregnancy, Gestational Diabetes Mellitus
CountriesSwitzerland
CollaboratorsUniversity Hospital, Zürich, Cantonal Hospital of Aarau, Switzerland, Vienna General Hospital, Paracelsus Medical University, University Hospital Freiburg

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedJan 14, 2014
Enrollment StartMay 1, 2014
Primary CompletionDec 31, 2018
TodayJul 2, 2026
Enrollment to primary: 4.7 yearsPosted 12.5 years ago